ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,629 | -38.2% | 21,371 | -32.7% | 0.00% | – |
| Q2 2023 | $51,159 | -83.3% | 31,776 | -70.0% | 0.00% | – |
| Q1 2023 | $306,716 | -12.6% | 105,764 | -1.1% | 0.00% | -100.0% |
| Q4 2022 | $350,921 | -11.6% | 106,988 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $397,000 | -52.1% | 104,924 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $829,000 | -12.4% | 106,478 | +4.5% | 0.00% | 0.0% |
| Q1 2022 | $946,000 | -44.5% | 101,845 | -5.9% | 0.00% | -50.0% |
| Q4 2021 | $1,706,000 | -7.5% | 108,237 | +5.0% | 0.00% | 0.0% |
| Q3 2021 | $1,845,000 | +4.2% | 103,078 | -9.5% | 0.00% | 0.0% |
| Q2 2021 | $1,771,000 | +2.0% | 113,912 | -5.8% | 0.00% | 0.0% |
| Q1 2021 | $1,737,000 | -22.7% | 120,942 | +5.6% | 0.00% | -33.3% |
| Q4 2020 | $2,247,000 | +58.4% | 114,482 | +4.5% | 0.00% | +50.0% |
| Q3 2020 | $1,419,000 | +12.5% | 109,529 | +26.5% | 0.00% | 0.0% |
| Q2 2020 | $1,261,000 | +90.5% | 86,571 | +11.3% | 0.00% | +100.0% |
| Q1 2020 | $662,000 | -48.9% | 77,762 | -1.1% | 0.00% | -50.0% |
| Q4 2019 | $1,295,000 | +14.3% | 78,639 | -2.0% | 0.00% | 0.0% |
| Q3 2019 | $1,133,000 | -17.5% | 80,227 | +17.5% | 0.00% | -33.3% |
| Q2 2019 | $1,374,000 | -46.2% | 68,303 | +6.3% | 0.00% | -40.0% |
| Q1 2019 | $2,553,000 | +11.9% | 64,225 | -2.2% | 0.01% | 0.0% |
| Q4 2018 | $2,281,000 | -14.1% | 65,653 | +2.3% | 0.01% | 0.0% |
| Q3 2018 | $2,654,000 | +16.0% | 64,173 | +3.1% | 0.01% | 0.0% |
| Q2 2018 | $2,287,000 | +17.0% | 62,223 | +24.2% | 0.01% | +25.0% |
| Q1 2018 | $1,954,000 | +156.1% | 50,110 | +18.9% | 0.00% | +100.0% |
| Q4 2017 | $763,000 | +14.4% | 42,159 | +4.6% | 0.00% | +100.0% |
| Q3 2017 | $667,000 | +5.7% | 40,323 | -10.6% | 0.00% | 0.0% |
| Q2 2017 | $631,000 | -32.8% | 45,104 | -1.3% | 0.00% | -50.0% |
| Q1 2017 | $939,000 | +38.1% | 45,704 | -4.6% | 0.00% | +100.0% |
| Q4 2016 | $680,000 | -35.4% | 47,904 | -2.6% | 0.00% | -50.0% |
| Q3 2016 | $1,052,000 | -4.0% | 49,204 | +1.0% | 0.00% | 0.0% |
| Q2 2016 | $1,096,000 | +60.0% | 48,704 | +35.3% | 0.00% | +100.0% |
| Q1 2016 | $685,000 | -16.9% | 36,000 | +15.4% | 0.00% | -50.0% |
| Q4 2015 | $824,000 | -14.8% | 31,200 | +1.4% | 0.00% | -33.3% |
| Q3 2015 | $967,000 | -30.7% | 30,764 | +16.2% | 0.00% | 0.0% |
| Q2 2015 | $1,396,000 | +166.4% | 26,464 | +110.0% | 0.00% | +200.0% |
| Q1 2015 | $524,000 | +83.2% | 12,600 | +17.8% | 0.00% | 0.0% |
| Q4 2014 | $286,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $1,480,000 | 7.58% |
| Redmile Group, LLC | 6,280,813 | $9,295,603 | 0.44% |
| Arctis Global LLC | 397,046 | $587,628 | 0.32% |
| Baupost Group | 9,773,616 | $14,465 | 0.28% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 230,000 | $413,400 | 0.24% |
| MAVERICK CAPITAL LTD | 6,290,713 | $9,310,255 | 0.21% |
| 683 Capital Management, LLC | 1,200,000 | $1,776,000 | 0.14% |
| STALEY CAPITAL ADVISERS INC | 1,000,000 | $1,480,000 | 0.08% |
| WASATCH ADVISORS LP | 8,399,229 | $12,430,859 | 0.08% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $777,000 | 0.07% |